April 4, 2003

FOR: ZOLL Medical Corporation

Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655
PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832



Burlington, MA  Friday, April 04, 2003 – – For the second year in a row, ZOLL Medical Corporation (Nasdaq: ZOLL), a global manufacturer of non-invasive cardiac resuscitation devices, has won a NorthFace ScoreBoard Award presented by the Omega Management Group Corporation. The annual award is presented to companies that demonstrate exemplary customer service and exceed customer expectations. The two service categories in which ZOLL was recognized both in 2001 and 2002 were technical support, and order, shipment, and delivery.

Omega Executive Vice President Harry Rich presented the award at ZOLL’s Burlington, Mass. headquarters on Friday, April 4, saying, “This award recognizes the commitment ZOLL’s service departments have made to ensure that the company’s customers receive the highest quality service. Winning this prestigious honor two years in a row affirms the consistency of service excellence ZOLL customers can expect.”

To qualify for the NorthFace ScoreBoard Award, a company must meet four criteria: 1) senior management commitment to exceeding customer expectations; 2) customer satisfaction program which identifies and corrects customer problems; 3) measure the level of customer satisfaction with product/service; and, 4) achieve an overall score of 4.0 out of 5.0 for a year. In ZOLL’s case, Omega conducted quarterly telephone surveys with 100 customers to determine level of achievement and quantify results.

“While providing excellent customer service is a goal of every product or service company, achieving it and being recognized for doing so is not an everyday occurrence,” comments Richard A. Packer, President and Chief Executive Officer of ZOLL. “I am proud of those ZOLL employees in our customer service, shipping and technical service departments who have earned this well-deserved honor.”

Since 1984, Omega has been a leader in providing customer satisfaction and retention programs by successfully partnering with clients to achieve the goal of World Class Customer Organization. Based in Chelmsford, Mass., Omega is grounded in the service side of a cross section of industries. Its mission is to provide organizations with competitive advantage by delivering customer intelligence data that increases customer satisfaction and loyalty. For more information, visit www.omegascoreboard.com.

ZOLL Medical Corporation, headquartered in Burlington, MA, designs, manufactures and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. Used by health care professionals to provide both types of cardiac resuscitation—pacing and defibrillation—these products are essential in the emergency treatment of cardiac arrest victims, both inside and outside the hospital. ZOLL also designs and markets software that automates collection and management of both clinical and non-clinical data for emergency medical service providers. ZOLL has operations in the United States, Canada, United Kingdom, Germany, France, the Netherlands and Australia, and business partners in all of the world’s major markets. For more information about ZOLL and its products, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the anticipated development of ZOLL’s business, the intent, belief or current expectations of ZOLL, its directors or its officers, primarily with respect to ZOLL’s business model and future operating performance of ZOLL, including expectations regarding results in future periods, operating performance and contributions to results from ZOLL’s new Public Access Defibrillation product, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the ZOLL’s Annual Report on Form 10-Q filed on February 12, 2003, including the future performance of the direct sales operations, as well as uncertainties regarding the market, acceptance and profitability of the ZOLL AED Plus and M Series CCT, the length and severity of the current economic slowdown and its impact on capital spending budgets, the reduction in overall capital equipment expenditures in the hospital and pre-hospital markets, the impact of governmental budget restraints on the purchase of capital equipment, the impact of the continued war on terrorism, the potential disruption in the transportation industry on ZOLL’s supply chain and product distribution channels, and the desire or ability of other parties to purchase ZOLL’s products.

# # #